WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
www.bms.com
.
Bristol-Myers Squibb RSS Channel
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category Bristol-Myers Squibb
Title
Published Date
Bristol-Myers Squibb Foundation announces $6 million in grants
10 June 2012
ORENCIA® (abatacept) demonstrates comparable efficacy to Humira® (adalimumab)
06 June 2012
Bristol-Myers Squibb announces global collaboration with leading academic institutions
29 May 2012
Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India
15 May 2012
Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership
15 May 2012
Bristol-Myers Squibb delivers a solid first quarter
27 April 2012
Bristol-Myers Squibb and Duke Translational Medicine Institute form strategic relationship
29 February 2012
Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia
19 February 2012
Bristol-Myers Squibb Completes Acquisition of Inhibitex, Inc.
13 February 2012
Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex
08 February 2012
Bristol-Myers Squibb delivers solid fourth quarter capping a year highlighted by new product approvals
26 January 2012
Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million to Support Cancer Patients
19 January 2012
Bristol-Myers Squibb to Acquire Inhibitex
08 January 2012
Simcere and Bristol-Myers Squibb Enter Innovative Partnership
14 December 2011
Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals
04 December 2011
Bristol-Myers Squibb Foundation's Together on Diabetes® Initiative Marks First Anniversary
14 November 2011
ASLAN Pharmaceuticals and Bristol-Myers Squibb Enter Innovative Partnership
03 November 2011
Bristol-Myers Squibb Delivers Strong Third Quarter
28 October 2011
Bristol-Myers Squibb Announces Changes in Senior Management Team
20 October 2011
Bristol-Myers Squibb Foundation Announces Collaboration with World Health Organization's Stop TB Department
11 October 2011
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Business & Industry
Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
Research & Development
Candidate found to inhibit malignant melanoma growth
A nasal spray protects against coronavirus infection - Effective also against recent immune-evasive variants
'Biohybrid' device could restore function in paralysed limbs
Scientists use tardigrade proteins for human health breakthrough
DNA treatment could delay paralysis that strikes nearly all patients with ALS
Scientists reveal a potential new approach to treating liver cancer
Normalizing tumor blood vessels may improve immunotherapy against brain cancer
Conferences & Events
SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
SAE Media Group's 6th annual 3D Cell Culture Conference
CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
CPHI Excellence in Pharma Award Winners 2022
CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
FDA approves first over-the-counter naloxone nasal spray
FDA grants Accelerated Approval for Alzheimer's disease treatment
FDA approves new HIV drug for adults with limited treatment options
FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
FDA approves first gene therapy to treat adults with Hemophilia B
You are here:
Home
Bristol-Myers Squibb
Bristol-Myers Squibb and Harvard announce new fibrosis research collaboration